Clinical trials
Suspended Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| AstraZeneca | 1 |
| Chongqing Precision Biotech Co., Ltd | 1 |
| City of Hope Medical Center | 1 |
| DNAtrix, Inc. | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| MetaPhore Pharmaceuticals | 1 |
| National Cancer Institute (NCI) | 1 |
| NextPoint Therapeutics, Inc. | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 16 |
| Colorectal Neoplasms | 3 |
| Melanoma | 3 |
| Breast Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Prostatic Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.